The global airway clearance devices market size valued USD 509.6 million in 2020 and expected to reach USD 786.2 million by 2027, at a CAGR of 6.3% during the forecast period 2021-2027 owing to increase in the prevalence of respiratory diseases all over the world. Rising incidences of respiratory diseases such as COPD, asthma, and other lung infections, and prevalence of diseases such as cystic fibrosis, chronic diffuse bronchiectasis, neuromuscular diseases and immotile ciliary dysfunction/primary ciliary dyskinesia. Airway clearance devices are used to clear out any infections present in the respiratory tract and make it clear without any obstacles. Additionally, due to the limitations of the earlier practice of traditional chest physiotherapy, high patient compliance to the respiratory clearance devices, lower costs and increased awareness are expected to enhance the sales of the market. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global airway clearance devices market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).